secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alpha Teknova, Inc. (TKNO)
CIK:        0001850902
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0000950170-23-062023
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teknova Q3 revenue $8.2M, down 24% YoY; net loss $10.2M; raised $22.9M equity, trimmed debt
--------------------------------------------------------------------------------

- Q3 revenue $8.2M (-24% YoY); Lab Essentials $7.3M (-23%), Clinical Solutions $0.6M (-35%).
- Net loss $10.2M ($0.34/share) vs $22.5M ($0.80/share) prior year; adjusted EBITDA -$5.5M.
- Gross margin fell to 18.0% from 44.6% due to lower revenue and fixed cost underabsorption.
- Raised $22.9M equity capital; repaid $10.0M long-term debt; expects FY free cash outflow <$30M.
- FY2023 revenue now expected at low end of $37-40M guidance range.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850902/000095017023062023/0000950170-23-062023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850902/000095017023062023/tkno-20231109.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-062023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer